Mount Sinai Receives $4 Million Gift to Support Prostate Health and Urology Department
Mount Sinai has received a $4 million donation from Lizzie and Jonathan Tisch to support prostate health and the Milton and Carroll Petrie Department of Urology at Mount Sinai.
The prostate program located at 625 Madison Avenue and founded by Ash Tewari, MBBS, MCh, Kyung Hyun Kim, MD Professor and Chair of Urology will be named The Lizzie and Jonathan Tisch Center for Prostate Health.
“The Lizzie and Jonathan Tisch Center for Prostate Health is transforming prostate cancer treatment and we are pleased to continue to support Dr. Tewari’s innovative and important work in helping to treat this disease and improve overall patient care,” said Jonathan Tisch, Co-Chairman of the Board of the Loews Corporation and Chairman & CEO of Loews Hotels & Co. With this visionary gift, Lizzie and Jonathan Tisch continue their generous history of philanthropic giving at Mount Sinai, improving prostate health for generations to come.
According to the American Cancer Society, one in nine men will be diagnosed with prostate cancer in their lifetime, making it the most common cancer among men other than skin cancer. While it is a serious disease, prostate cancer is treatable if caught early.
“I am extremely grateful for Lizzie and Jonathan’s ongoing commitment to help better the lives of our patients,” said Dr. Tewari, a world-renowned urologist and prostate cancer specialist. “This gift provides our department with an elevated level of care for patients while also fostering research opportunities for our experts to continue to be pioneers in the field.”
The medical services provided at the Lizzie and Jonathan Tisch Center for Prostate Center include state-of-the-art prostate cancer screening and imaging technologies, precision urology, focal therapy, targeted biopsies, robotics for prostate cancer surgery, prostate cancer fusion biopsy, and active surveillance. Additionally, prostate cancer experts such as Dr. Tewari; Avinash Reddy, MD; Sujit Nair, PhD; Robert Valenzuela; MD; Michael Palese, MD; and Steven Kaplan, MD, are available to see patients at the newly named Center.
The Department of Urology at the Mount Sinai Health System has one of the most robust robotic surgery programs in the country, with Dr. Tewari having performed more than 7,000 surgeries. Genomic testing and advanced imaging are routine for patients with prostate cancer, providing personalized and precise treatment protocols.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.